It's all changing at Zeiss

Recent acquisitions, division restructuring, and management changes prove that Carl Zeiss Meditec is very much committed to change. Ophthalmology Times Europe spoke with CEO, Dr Michael Kaschke about the challenges that he faces in an ever evolving market.

Related Content:

Cataract & Refractive

Combined MIGS and cataract surgery option offers positive results

Investigators analyse factors associated with patient satisfaction after refractive surgery

Phaco power modulation boosts safety, efficacy in cataract surgery